Vascular endothelial growth factor and ocular neovascularization.
about
Structural characterization of a recombinant fusion protein by instrumental analysis and molecular modelingCorticotropin-releasing factor receptor 2 is a tonic suppressor of vascularizationMicrovascular patterning is controlled by fine-tuning the Akt signal.Animal models of choroidal and retinal neovascularization.Modulation of thrombospondin 1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetesAnti-angiogenic and anti-inflammatory effects of SERPINA3K on corneal injury.The mechanism of (R,R) ZX-5 on increasing NO releaseRETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.Development of an experimental model of proliferative retinopathy by intravitreal injection of VEGF165.Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor.Evaluation of pharmacological activities and assessment of intraocular penetration of an ayurvedic polyherbal eye drop (Itone™) in experimental modelsExpression of thrombospondin-1 modulates the angioinflammatory phenotype of choroidal endothelial cells.Identification of a novel inhibitor of the canonical Wnt pathway.Contributions of VEGF to age-dependent transmural gradients in contractile protein expression in ovine carotid arteriesIntravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report.Long-term visual outcomes in extremely low-birth-weight children (an American Ophthalmological Society thesis)Decreased K5 receptor expression in the retina, a potential pathogenic mechanism for diabetic retinopathyFormation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cellsSerum vascular endothelial growth factor is a potential biomarker of metastatic recurrence after curative resection of hepatocellular carcinoma.Nitrosative stress plays an important role in Wnt pathway activation in diabetic retinopathySmall Molecular-Sized Artesunate Attenuates Ocular Neovascularization via VEGFR2, PKCα, and PDGFR Targets.Nanoparticle-mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes-induced retinal vascular leakageAntisense oligonucleotide therapy in diabetic retinopathyDevelopment of Anti-VEGF Therapies for Intraocular Use: A Guide for Clinicians.Bioinformatics analysis to identify the differentially expressed genes of glaucomaIncreased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease.Thrombin-induced VEGF expression in human retinal pigment epithelial cellsExacerbation of retinal degeneration and choroidal neovascularization induced by subretinal injection of Matrigel in CCL2/MCP-1-deficient mice.Transgenic mice model of ocular neovascularization driven by vascular endothelial growth factor (VEGF) overexpression.Topical administration of regorafenib eye drops: Phase I dose-escalation study in healthy volunteers.Safe dose of intravitreal imatinib and its effect on laser-induced choroidal neovascularization: a rat-model experiment.
P2860
Q28487616-059BD103-1F90-46A4-91DB-E0DBC35DCC63Q28511231-05DAD668-E207-4C7B-94B4-67129BD94D1DQ33551411-892AB601-DF40-4C62-B9DA-932556DD44C3Q33582933-C9B41FBE-A128-485D-ABDF-07F5E07D77B3Q33642146-EEDF0FF1-7B9D-4230-AC9E-32F4E1465A7AQ33815623-16D5488A-F4E5-4CDD-98F6-2B2F414DAE44Q34205628-1B827460-D34B-49ED-8ADA-7FEB34CDB5A4Q34283230-9B180AAD-FA76-45F3-9858-2641D4ED1766Q34454886-679EA8FD-A4C0-40B0-9DBF-437D75AD1850Q34477473-C9526F26-760A-4B14-80B8-92379DC41244Q34528903-F61DD603-DEA5-4834-B6BC-C8E510EB9A95Q34790591-1149AB69-1340-4519-8B21-2F6E6A00EB5DQ35096644-A4E3A68A-0A17-4DFF-9F7C-A45B5E801089Q35216861-7FD2E4D2-1BD2-43F4-8E93-7C4B6712AADAQ35519205-EBAB73EE-CAF3-4A40-8ED3-CB53AA9D56B4Q35662653-5D5EBFF4-7DEF-4CFE-BD71-9633AB778C78Q35768511-9DA95BBA-907A-4861-B1C9-A812E0D41A3BQ35787897-F9A70480-B58C-4DC0-A56C-7F3C4B20A565Q36492038-9DB6272E-1617-4DD0-B914-3021DC5DB908Q36629924-908A1C4C-8157-4423-ADEC-62E339C2131DQ37144488-AD177F8F-9F10-45F7-B2D5-8B602DB80918Q37267083-9A381562-E22A-49E5-8D5F-331D9321DFD5Q37404573-2026BF2D-1E52-48E5-9278-B535E473553BQ37973348-C6E1958B-393E-480A-B257-A222BC73903CQ38461206-CCACCB16-561F-45F2-92F2-C74347401CACQ40753351-68EC2BB7-A263-4228-880B-9FCD66355A2CQ42115589-48571418-18C7-4AAA-835D-0C4289465B78Q42448644-B4A25667-E397-441E-946D-48CE7672D1BAQ42838776-D5D7BDAB-8F3F-4FF7-879C-98A3EB3507AEQ50119662-1EC18820-068E-48F7-A831-567C25503A21Q51099974-44E09D0D-F9C4-4CDE-A088-CC814C0700D5
P2860
Vascular endothelial growth factor and ocular neovascularization.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Vascular endothelial growth factor and ocular neovascularization.
@ast
Vascular endothelial growth factor and ocular neovascularization.
@en
type
label
Vascular endothelial growth factor and ocular neovascularization.
@ast
Vascular endothelial growth factor and ocular neovascularization.
@en
prefLabel
Vascular endothelial growth factor and ocular neovascularization.
@ast
Vascular endothelial growth factor and ocular neovascularization.
@en
P2860
P1476
Vascular endothelial growth factor and ocular neovascularization
@en
P2093
P2860
P407
P50
P577
1997-07-01T00:00:00Z